Stephens Got Codexis (NASDAQ:CDXS) Covered with $16 Target.

May 17, 2018 - By Jack Shaw

Codexis, Inc. (NASDAQ:CDXS) Corporate Logo

Big Money Sentiment decreased to 2.17 in Q4 2017. It has change of 0.03, from 2017Q3’s 2.2. The ratio dived due to Codexis, Inc. positioning: 3 sold and 15 reduced. 12 funds amassed holdings and 27 increased holdings. Investors holded 25.60 million in 2017Q3 but now own 28.02 million shares or 9.42% more.

107,089 were accumulated by Deutsche National Bank Ag. Goldman Sachs Gru has invested 0% of its capital in Codexis, Inc. (NASDAQ:CDXS). Wells Fargo & Company Mn accumulated 1.00M shs or 0% of the stock. 56,040 are held by White Pine Cap Ltd Liability. Legal General Public Limited Liability Corp reported 9,457 shs or 0% of all its holdings. Northern, a Illinois-based fund reported 429,439 shs. 27,476 were reported by Amer Intll Group. Guggenheim Capital Limited Liability Co reported 0% of its capital in Codexis, Inc. (NASDAQ:CDXS). Vanguard Inc reported 0% stake. Bancorporation Of Montreal Can reported 0% of its capital in Codexis, Inc. (NASDAQ:CDXS). 59,726 were reported by Laurion Capital Mgmt Limited Partnership. Barclays Public Ltd Company has 6,470 shs. Cortina Asset Mgmt Limited Liability Company invested in 1.01M shs. 1.84 million were reported by Baillie Gifford And. Balyasny Asset Mgmt Ltd Liability accumulated 11,845 shs or 0% of the stock.

Codexis, Inc. registered $1.45 million net activity with 0 insider buys and 6 insider sales since March 21, 2018. On Monday, March 26 WOLF DENNIS P sold $464,384 worth of Codexis, Inc. (NASDAQ:CDXS). On Thursday, March 22 NICOLS JOHN J sold $259,828 worth of Codexis, Inc. (NASDAQ:CDXS). Smith David V sold $62,213 worth of Codexis, Inc. (NASDAQ:CDXS) or 6,000 shs on Tuesday, April 3. $259,930 worth of stock was sold by Lalonde James on Monday, May 14. On Wednesday, March 28 BARUCH THOMAS R sold $276,318 worth of Codexis, Inc. (NASDAQ:CDXS) or 25,000 shs.

What Price Target Has Stephens Given Codexis (NASDAQ:CDXS)

Today a research report was revealed, in which Stephens analyst has begun coverage of Codexis (NASDAQ:CDXS) with Overweight rating. The Stock analysts give $16 PT which would suggest upside potential of 14.70 % on CDXS’s shares.

Codexis, Inc. (NASDAQ:CDXS) Ratings Coverage

Total analysts of 2 have positions in Codexis (NASDAQ:CDXS) as follows: 2 rated it a “Buy”, 0 with “Sell” and 0 with “Hold”. The positive are 100%. The firm has $1600 highest while $11.5 is the lowest target price. The average target $13.75 is -1.43% below the last ($13.95) price. Since March 12, 2018 according to StockzIntelligence Inc Codexis has 2 analyst reports. On Monday, March 12 the rating was maintained by H.C. Wainwright with “Buy”. In Wednesday, May 16 report Stephens initiated it with “Buy” rating and $1600 target.

The stock increased 5.28% or $0.7 during the last trading session, reaching $13.95.Codexis, Inc. has 602,084 shares volume, 41.77% up from normal. CDXS is uptrending and has moved 125.77% since May 17, 2017. CDXS outperformed the S&P500 by 114.22%.

Earnings report for Codexis, Inc. (NASDAQ:CDXS) is anticipated on August, 8., Zacks reports. This year’s earnings per share analyst estimate is anticipated to be $-0.03. That is 76.92 % up compareed to $-0.13 earnings per share for last year. -70.00 % EPS growth is what Wall Street’s predicts after $-0.10 reported EPS last quarter.

Codexis, Inc. discovers, develops, and sells protein catalysts.The company has $742.70 million market cap. It also offers intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable clients to perform chemistry screening.Last it reported negative earnings. The firm also provides protein catalyst screening and protein engineering services.

For more Codexis, Inc. (NASDAQ:CDXS) news brought out recently go to: Seekingalpha.com, Globenewswire.com, Nasdaq.com, Globenewswire.com or Seekingalpha.com. The titles are as follows: “Premarket analyst action – healthcare” brought out on May 16, 2018, “Codexis Reports First Quarter 2018 Financial Results” on May 10, 2018, “3 High-Growth Stocks That Are Just Getting Started” with a publish date: May 12, 2018, “Codexis to Hold First Quarter 2018 Conference Call on May 10” and the last “Codexis’ (CDXS) CEO John Nicols on Q1 2018 Results – Earnings Call Transcript” with publication date: May 11, 2018.

Codexis, Inc. (NASDAQ:CDXS) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: